Maravai LifeSciences
MRVI
$7.84
Share price
1.88%
Change (1 day)
-43.11%
Change (1 year)
Categories
Maravai LifeSciences (MRVI) - Cash on Hand
Cash on Hand as of December 2023 : $0.57 B
According to Maravai LifeSciences
's latest financial reports the company has $0.57 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Maravai LifeSciences - Cash on Hand chart (from 2019 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $0.57 B | -9.04% |
| 2022-12-31 | $0.63 B | 14.67% |
| 2021-12-31 | $0.55 B | 133.41% |
| 2020-12-31 | $0.23 B | 856.21% |
| 2019-12-31 | $24.7 M | 12.96% |
| 2018-12-31 | $21.86 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Organovo ONVO | $5.29 M | -99.08% | 🇺🇸 USA |
 Orchard Therapeutics
ORTX | $0.12 B | -78.19% | 🇬🇧 UK |
 Novavax NVAX | $0.56 B | -1.12% | 🇺🇸 USA |
 Novocure
NVCR | $0.91 B | 58.38% | Jersey |